Your browser doesn't support javascript.
loading
Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches.
Wang, Xiaoli; He, Xiujing; Liu, Junzhi; Zhang, Haiyan; Wan, Hangyu; Luo, Jing; Yang, Jiqiao.
Afiliação
  • Wang X; Breast Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • He X; Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Liu J; Laboratory of Tumor Targeted and Immune Therapy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang H; West China School of Medicine/West China Hospital, Sichuan University, Chengdu, China.
  • Wan H; Department of Breast Surgery, Sichuan Provincial Maternity and Child Health Care Hospital, Chengdu, China.
  • Luo J; Department of Breast Surgery, Sichuan Provincial Maternity and Child Health Care Hospital, Chengdu, China.
  • Yang J; Department of Breast Surgery, Sichuan Provincial Maternity and Child Health Care Hospital, Chengdu, China.
Front Immunol ; 15: 1295759, 2024.
Article em En | MEDLINE | ID: mdl-38529282
ABSTRACT
Idiopathic granulomatous mastitis (IGM) is a noncancerous, chronic inflammatory disorder of breast with unknown causes, posing significant challenges to the quality of life due to its high refractoriness and local aggressiveness. The typical symptoms of this disease involve skin redness, a firm and tender breast mass and mastalgia; others may include swelling, fistula, abscess (often without fever), nipple retraction, and peau d'orange appearance. IGM often mimics breast abscesses or malignancies, particularly inflammatory breast cancer, and is characterized by absent standardized treatment options, inconsistent patient response and unknown mechanism. Definite diagnosis of this disease relies on core needle biopsy and histopathological examination. The prevailing etiological theory suggests that IGM is an autoimmune disease, as some patients respond well to steroid treatment. Additionally, the presence of concurrent erythema nodosum or other autoimmune conditions supports the autoimmune nature of the disease. Based on current knowledge, this review aims to elucidate the autoimmune-favored features of IGM and explore its potential etiologies. Furthermore, we discuss the immune-mediated pathogenesis of IGM using existing research and propose immunotherapeutic strategies for managing this condition.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eritema Nodoso / Mastite Granulomatosa Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eritema Nodoso / Mastite Granulomatosa Limite: Female / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article